Our Mission
We will seek to disseminate the culture of innovation that can be developed within the academy according to the demands of the industrial productive sector. Data from the United Nations (UN) indicate that oral diseases affect about 3.5 billion people worldwide, and Academy-Industry interaction can speed up the development of nanobiotechnological and artificial intelligence solutions in an innovative and sustainable for Dental Industry 4.0.
​
Research is connected with industry demands and focused on the development of photonic, lipidomics and electrochemical saliva diagnostic platforms for oral and systemic diseases using artificial intelligence algorithms and results released on smartphones.
​
Additionally, we seek to develop new molecules based on nanomaterials, bioinformatics and artificial intelligence for application in frontier-of-knowledge therapies and prophylaxis addressed to infectious and chronic-degenerative diseases.
Chronic-degenerative diseases (diabetes, CKD and asthma), infectious (COVID-19, Zika Virus, Chicungunya Virus, Monkeypox, Chapare Virus, tuberculosis, Hepatitis, HPV) and metastatic (Oral Cancer and Breast Cancer).
Our Story
Graduated in Dentistry from the University of Passo Fundo (2004), master's degree (2007) and doctorate (2010) in Sciences (Human Physiology concentration area) from the University of São Paulo with scholarships from the National Council for Scientific and Technological Development (CNPq) and from the Research Support Foundation of the State of São Paulo (FAPESP), respectively. He also carried out a post-doctorate with a FAPESP scholarship at the Institute of Biomedical Sciences at USP and carried out technical-scientific internships in Japan (Osaka Dental University; University of Tsukuba), in the USA (Pacific University; University of Rochester Medical Center) and Scotland/United Kingdom (University of Strathclyde). He was Visiting Professor at the University of Saskatchewan (College of Dentistry, Saskatoon, Canada) 2019-2020.
Sabino-Silva performed various activities of academic representation. He was an adjunct professor at the Federal University of Alagoas (UFAL, 2011-2014) and was also the first Coordinator of the Committee on Ethics in the Use of Animals CEUA/UFAL. He is currently an adjunct professor, on a full-time basis, at the Federal University of Uberlândia (UFU). He is a permanent researcher and member of the Board of the PPG Immunologia e Parasitologia Aplicadas (PPIPA, 2021-2023, CAPES 7), is a permanent researcher and was a member of the Board of the PPG in Dentistry-UFU (2015-2019; CAPES 6) and is a permanent researcher and was coordinator of the PPG in Health Sciences (PPCSA-FAMED-UFU, CAPES 6) from 2017-2019. He was the first President of the Brazilian Group of Researchers in Salivary Gland and Saliva. CNPq thematic project coordinator in the area of ​​Niobium for the development of INMETRO and ANVISA guidelines for the use of Niobium in Health Industries.
He was also a member of the Commission on Technological Development and Innovation PIBITI - UFU (2013-2015), is currently a Member of the UFU 4.0 Innovation Commission and is also an effective member of the UFU Innovation Policy Commission. He serves on the Management Committee of REBIR and the Minas Gerais Research Networks. He was a member of the Fiscal Council of the Brazilian Society of Physiology - SBFis (2013-2016).He is currently coordinator of the Research Group on Integrative Physiology and Salivary Nanobiotechnology, deputy coordinator of the National System of Nanotechnology Laboratories (SisNANO UFU). and member of the INCT TeraNano Innovation core (Theranostics and Nanobiotechnology). Member of the Advisory Board and Innovation Core of the INCT in Oral Health and Dentistry.
Develops activities to encourage innovation and development of new products in undergraduate and graduate courses. Acting as a PPSUS specialist (Ministry of Health/Innovation). His research in Nanobiotechnology and the application of Artificial Intelligence in diagnostics, particularly for infectious oral and systemic diseases, has had a significant impact, as evidenced by his numerous awards, including the IADR Hatton Competition (the most prestigious award in Brazilian dentistry), the Scientific Panel Award of the Brazilian Society for Dental Research (the second most important award in Brazilian dentistry), and two international Latin American Research Awards (LARA) from Google.
​
Sabino-Silva has:
-
17 patents filed with the INPI and 4 patents filed via the International PCT;
-
>70 international articles.
-
H index: 23;
-
Citations: >2500;
He completed the supervision of 4 postdoctoral researchers, >10 doctoral researchers, >20 master's researchers and >20 students of Technological Scientific Initiation.
He was the first coordinator of the Brazilian Group of Researchers in Salivary Glands and Saliva. He researches Innovation applications mainly in the following topics: Development of new nanobiotechnological platforms with diagnostic and therapeutic applications in saliva-based chronic degenerative and infectious diseases.
